ClinicalTrials.Veeva

Menu

Comparing Air Embolic Load in Two Venous Cannulation Methods, 40 Patients Undergoing Elective Valve Surgery.

P

Petronella Torild

Status

Completed

Conditions

Air Embolism
Extracorporeal Circulation; Complications

Treatments

Diagnostic Test: Volume control

Study type

Interventional

Funder types

Other

Identifiers

NCT05820828
2023-00204-01

Details and patient eligibility

About

The goal of this single center prospective controlled observational and interventional trial is to investigate and compare origin of air emboli when different venous cannulation methods is used in patients undergoing cardiac surgery with extracorporeal circulation.

40 consecutive elective patients will be included in two groups, depending on the procedure requiring bicaval or cavoatrial cannulation. After assorted into respective group, patients will be block randomized (five groups consisting of eight patients each) to either intervention group (low venous reservoir volume, 200-300 mL) or control group (venous reservoir volume > 300 mL).

Primary endpoint is to investigate if the amount of air emboli passing through the oxygenator to the arterial line differs between bicaval and cavoatrial venous cannulation during extracorporeal circulation. Secondary endpoints are the relative difference in amount air emboli between the groups, if there is any correlation between the amount of air in venous line and the amount of air passing through the oxygenator to the arterial line during extracorporeal circulation, and if difference is seen on the amount of air passing through the oxygenator depending on the level of volume in the venous reservoir.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 years
  • Elective bicaval cannulation (mitral valve repair/replacement (MVR) or MVR + coronary artery bypass grafting (CABG))
  • Elective cavoatrial cannulation (aortic valve repair/replacement (AVR) or AVR + CABG
  • Planned normothermia (35-37˚C)

Exclusion criteria

  • Acute heart surgery
  • Adult Congenital Heart Disease (ACHD) surgery
  • Endocarditis
  • Reoperation (primary procedure > 2 years ago)
  • Perioperative iatrogenic adverse events (major bleeding, aortic dissection, other severe complications)

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Control group
No Intervention group
Description:
Patient will during extracorporeal circulation be monitored and held in the range of \> 300 mL in the venous reservoir. Patient will recieve fluid if needed to maintain correct level (crystalloids, colloids or erytrocytes depending on patients clinical status).
Interventional group
Experimental group
Description:
Patient will during extracorporeal circulation be monitored and held in the range of 200 - 300 mL in the venous reservoir. To maintain correct level of volume, any excessive fluid will be drained into a sterile infusion bag during extracorporeal circulation. After the surgery, the patient will recieve the volume to ensure correct volume status.
Treatment:
Diagnostic Test: Volume control

Trial contacts and locations

1

Loading...

Central trial contact

Petronella AE Torild, Student; Tor Damén, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems